Scotland · NHS Scotland MSAN
Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials
MSAN(2024)29 · Level 2 · issued 30 May 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 3. Alternative beta2-agonists for nebulisation and intravenous administration remain available, | Available | — |
| however, they cannot support an increase in demand. | Available — cannot support uplift | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.